Uncategorized
VIDEO: Promising results from 3-year data on microshunt for glaucoma treatment
SAN FRANCISCO — At the Glaucoma 360: New Horizons Forum, Russ Trenary, president and CEO of InnFocus, discusses 3-year study results published in the Journal of Glaucoma of the efficacy of the InnFocus microshunt for lowering IOP -- alone, with mitomycin C or in combination with phacoemulsification.